Literature DB >> 6273803

Specific deletion of DNA sequences between preselected bases.

N Panayotatos, K Truong.   

Abstract

Blunt-end ligation of a "filled-in" HindIII, Sal I, Ava I or Bcl I restriction site with a DNA fragment having A, G, C, or T as the terminal 3' nucleotide regenerates the corresponding restriction site. A combination of this property with the action of BAL 31 nuclease which progressively removes base-pairs from the ends of linear DNA, can generate deletions extending to desired pre-selected nucleotides, and introduces unique restriction sites at those positions. Similarly other restriction sites can be used to select for the deletion of sequences between specific di-, tri-, tetra- and penta-nucleotides. Using this method, 10 base pairs were deleted from the end of a restriction fragment carrying the late promoter for bacteriophage T7 gene 1.1, to create a molecule with a unique restriction site at the initiation codon for translation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6273803      PMCID: PMC327552          DOI: 10.1093/nar/9.21.5679

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  11 in total

1.  Recognition and initiation site for four late promoters of phage T7 is a 22-base pair DNA sequence.

Authors:  N Panayotatos; R D Wells
Journal:  Nature       Date:  1979-07-05       Impact factor: 49.962

2.  In vitro mutagenesis of a circular DNA molecule by using synthetic restriction sites.

Authors:  F Heffron; M So; B J McCarthy
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

3.  Cloning and localization of the in vitro functional origin of replication of bacteriophage T7 DNA.

Authors:  N Panayotatos; R D Wells
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

4.  A rapid microscale technique for isolation of recombinant plasmid DNA suitable for restriction enzyme analysis.

Authors:  R D Klein; E Selsing; R D Wells
Journal:  Plasmid       Date:  1980-01       Impact factor: 3.466

5.  Eukaryotic signal sequence transports insulin antigen in Escherichia coli.

Authors:  K Talmadge; S Stahl; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

6.  Targeted deletions of sequences from closed circular DNA.

Authors:  C Green; C Tibbetts
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

7.  Nucleotide sequence from the genetic left end of bacteriophage T7 DNA to the beginning of gene 4.

Authors:  J J Dunn; F W Studier
Journal:  J Mol Biol       Date:  1981-06-05       Impact factor: 5.469

8.  Rat insulin genes: construction of plasmids containing the coding sequences.

Authors:  A Ullrich; J Shine; J Chirgwin; R Pictet; E Tischer; W J Rutter; H M Goodman
Journal:  Science       Date:  1977-06-17       Impact factor: 47.728

9.  The 3'-terminal sequence of Escherichia coli 16S ribosomal RNA: complementarity to nonsense triplets and ribosome binding sites.

Authors:  J Shine; L Dalgarno
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

10.  Directed deletion of a yeast transfer RNA intervening sequence.

Authors:  R B Wallace; P F Johnson; S Tanaka; M Schöld; K Itakura; J Abelson
Journal:  Science       Date:  1980-09-19       Impact factor: 47.728

View more
  4 in total

1.  DNA replication regulated by the priming promoter.

Authors:  N Panayotatos
Journal:  Nucleic Acids Res       Date:  1984-03-26       Impact factor: 16.971

2.  Lytic action of cloned phi X174 gene E.

Authors:  K D Young; R Young
Journal:  J Virol       Date:  1982-12       Impact factor: 5.103

3.  Cleavage within an RNase III site can control mRNA stability and protein synthesis in vivo.

Authors:  N Panayotatos; K Truong
Journal:  Nucleic Acids Res       Date:  1985-04-11       Impact factor: 16.971

4.  General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.

Authors:  M Mackett; G L Smith; B Moss
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.